EQL Pharma AB (publ) (FRA:7JK)
Germany · Delayed Price · Currency is EUR 4.900
-0.005 (-0.10%)
At close: Nov 28, 2025
EQL Pharma AB Company Description
EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe.
It offers injection products for inpatient care and formulations for outpatient care. EQL Pharma AB (publ) was incorporated in 2006 and is based in Lund, Sweden.
EQL Pharma AB (publ)
| Country | Sweden |
| Founded | 2006 |
| Industry | Pharmaceutical Preparations |
| Employees | 21 |
| CEO | Axel Schorling |
Contact Details
Address: Stortorget 1 Lund, 222 23 Sweden | |
| Phone | 46 46 12 01 70 |
| Website | eqlpharma.com |
Stock Details
| Ticker Symbol | 7JK |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | SEK |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Axel Schorling | Chief Executive Officer |
| Anna Jonsson | Chief Financial Officer |
| Martin Kristofferson | Chief Operating Officer |